Syngenta has not taken its eye off the ball amid ongoing discussions with regulators over its $43 billion takeover by ChemChina, the chief executive of the Swiss agrichemicals giant told CNBC after the company reported sales and profit that missed expectations.
"Right now we're focused on only two things – our performance in the marketplace, our focus on customers...and growing our company. The second (thing) is to get the ChemChina deal done," Erik Fyrwald told CNBC Europe's "Squawk Box."
Syngenta still expects the ChemChina takeover to be completed by the end of 2016 although the deal has been delayed due to concerns among competition regulators. Fyrwald said a small team was continuously working on the deal and hoped it would be closed by the end of the year, however.
"We have had very constructive dialogues with the regulators around the world and those reinforce our confidence that we will get the deal closed by the end of the year and head into 2017 with full focus to drive our performance," he said.
On Friday, the firm reported sales that fell short of analyst forecasts, and warned that in the short term, the industry continued to see tough market conditions.